199:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
Glaucoma-drainage devices:@0.076190:0.084931:0.290578:0.084931:0.290578:0.068433:0.076190:0.068433:0.012700:0.003629:0.009979:0.009071:0.009676:0.009676:0.014212:0.009979:0.006350:0.009979:0.004838:0.009979:0.003629:0.009071:0.009979:0.009979:0.009676:0.004233:0.009979:0.009676:0.008467:0.003629:0.009676:0.009676:0.006652
18,19:@0.290588:0.079633:0.312686:0.079633:0.312686:0.070064:0.290588:0.070064:0.004911:0.004911:0.002455:0.004911:0.004911
Glaucoma-drainage devices are usually  used as sal-:@0.076190:0.101801:0.480927:0.101801:0.480927:0.086019:0.076190:0.086019:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005020:0.010357:0.004551:0.010326:0.003024:0.009223:0.010326:0.010175:0.009827:0.007635:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.005866:0.007635:0.010326:0.004551:0.009827:0.007635:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004188:0.003462:0.009192:0.005866:0.009827:0.010357:0.007635:0.010326:0.005866:0.007635:0.005866:0.010326:0.003024:0.005020
vage- and end-stage procedures in refractory glauco-:@0.076190:0.116106:0.480957:0.116106:0.480957:0.100323:0.076190:0.100323:0.008376:0.010326:0.010175:0.009827:0.005020:0.005020:0.010326:0.009223:0.010357:0.005020:0.009827:0.009223:0.010357:0.005020:0.005866:0.005125:0.010326:0.010175:0.009827:0.005020:0.010311:0.004551:0.009903:0.009782:0.009827:0.010357:0.009192:0.004551:0.009827:0.005866:0.005004:0.003024:0.009223:0.005020:0.004551:0.009827:0.004747:0.004551:0.010326:0.009782:0.005125:0.009903:0.004551:0.008104:0.005004:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.005020
ma. The first attempt at drainage surgery was in 1907, :@0.076190:0.130411:0.485115:0.130411:0.485115:0.114628:0.076190:0.114628:0.014182:0.010326:0.004188:0.005942:0.006441:0.009223:0.009812:0.005942:0.003681:0.003681:0.004551:0.005866:0.005125:0.005927:0.010326:0.005125:0.005125:0.009827:0.014182:0.010311:0.005125:0.005927:0.010326:0.005125:0.005942:0.010357:0.004551:0.010326:0.003024:0.009223:0.010326:0.010175:0.009827:0.005927:0.005866:0.009192:0.004551:0.010175:0.009827:0.004551:0.008104:0.005927:0.012564:0.010326:0.005866:0.005942:0.003024:0.009223:0.005942:0.008376:0.008376:0.008376:0.008376:0.004188:0.004188
but it was revolutionised in the late 1960s and early 1970s :@0.076190:0.144716:0.485145:0.144716:0.485145:0.128933:0.076190:0.128933:0.010311:0.009192:0.005125:0.003281:0.003024:0.005125:0.003281:0.012564:0.010326:0.005866:0.003281:0.004551:0.009827:0.008376:0.009903:0.003024:0.009192:0.005125:0.003024:0.009903:0.009223:0.003024:0.005866:0.009827:0.010357:0.003281:0.003024:0.009223:0.003281:0.005125:0.009223:0.009827:0.003266:0.003024:0.010326:0.005125:0.009827:0.003281:0.008376:0.008376:0.008376:0.008376:0.005866:0.003296:0.010326:0.009223:0.010357:0.003281:0.009827:0.010326:0.004551:0.003024:0.008104:0.003281:0.008376:0.008376:0.008376:0.008376:0.005866:0.004188
by Molteno who developed the first foot plate with the :@0.076190:0.159020:0.485145:0.159020:0.485145:0.143238:0.076190:0.143238:0.010311:0.008104:0.004732:0.013894:0.009903:0.003024:0.005125:0.009827:0.009223:0.009903:0.004717:0.012564:0.009223:0.009903:0.004717:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.004717:0.005125:0.009223:0.009827:0.004717:0.003681:0.003681:0.004551:0.005866:0.005125:0.004717:0.004747:0.009903:0.009903:0.005125:0.004717:0.010311:0.003024:0.010326:0.005125:0.009827:0.004717:0.012564:0.003024:0.005125:0.009223:0.004717:0.005125:0.009223:0.009827:0.004188
drainage device and explained the  pathophysiology :@0.076190:0.173325:0.485130:0.173325:0.485130:0.157543:0.076190:0.157543:0.010357:0.004551:0.010326:0.003024:0.009223:0.010326:0.010175:0.009827:0.007197:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.007197:0.010326:0.009223:0.010357:0.007197:0.009827:0.007257:0.010311:0.003024:0.010326:0.003024:0.009223:0.009827:0.010357:0.007197:0.005125:0.009223:0.009827:0.004188:0.002994:0.010311:0.010326:0.005125:0.009223:0.009903:0.010311:0.009223:0.008104:0.005866:0.003024:0.009903:0.003024:0.009903:0.010175:0.008104:0.004188
around bleb resistance.:@0.076190:0.187630:0.249198:0.187630:0.249198:0.171847:0.076190:0.171847:0.010326:0.004551:0.009903:0.009192:0.009223:0.010357:0.004188:0.010311:0.003024:0.009827:0.010311:0.004188:0.004551:0.009827:0.005866:0.003024:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.004188
There are two types of implants, one with a unidirec-:@0.090478:0.201935:0.480957:0.201935:0.480957:0.186152:0.090478:0.186152:0.006441:0.009223:0.009827:0.004551:0.009827:0.005095:0.010326:0.004551:0.009827:0.005110:0.005125:0.012564:0.009903:0.005095:0.005125:0.008104:0.010311:0.009827:0.005866:0.005110:0.009903:0.004747:0.005110:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866:0.004188:0.005110:0.009903:0.009223:0.009827:0.005095:0.012564:0.003024:0.005125:0.009223:0.005110:0.010326:0.005110:0.009192:0.009223:0.003024:0.010357:0.003024:0.004551:0.009827:0.009782:0.005020
tional restrictive flow/valve and those without that rely :@0.076190:0.216240:0.485145:0.216240:0.485145:0.200457:0.076190:0.200457:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005624:0.004551:0.009827:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.003024:0.008376:0.009827:0.005639:0.003666:0.003666:0.009903:0.012564:0.006607:0.008376:0.010326:0.003024:0.008376:0.009827:0.005639:0.010326:0.009223:0.010357:0.005639:0.005125:0.009223:0.009903:0.005866:0.009827:0.005624:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.005624:0.005125:0.009223:0.010326:0.005125:0.005624:0.004551:0.009827:0.003024:0.008104:0.004188
on pressure gradients for flow. :@0.076190:0.230545:0.297911:0.230545:0.297911:0.214762:0.076190:0.214762:0.009903:0.009223:0.004188:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.010175:0.004551:0.010326:0.010357:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004747:0.009903:0.004551:0.004188:0.003666:0.003666:0.009903:0.012564:0.004188:0.004188
Many implants have been developed, but have not :@0.090478:0.244849:0.485160:0.244849:0.485160:0.229067:0.090478:0.229067:0.013894:0.010326:0.009223:0.008104:0.005473:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866:0.005473:0.009223:0.010326:0.008376:0.009827:0.005473:0.010311:0.009827:0.009827:0.009223:0.005458:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.004188:0.005473:0.010311:0.009192:0.005125:0.005473:0.009223:0.010326:0.008376:0.009827:0.005473:0.009223:0.009903:0.005125:0.004188
remained  in  use  today.  Currently,  there  are  four  non-:@0.076190:0.259154:0.480957:0.259154:0.480957:0.243372:0.076190:0.243372:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.009827:0.010357:0.004188:0.002464:0.003024:0.009223:0.004188:0.002464:0.009192:0.005866:0.009827:0.004188:0.002464:0.005125:0.009903:0.010357:0.010326:0.008104:0.004188:0.004188:0.002464:0.012292:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.004188:0.002464:0.005125:0.009223:0.009827:0.004551:0.009827:0.004188:0.002464:0.010326:0.004551:0.009827:0.004188:0.002464:0.004747:0.009903:0.009192:0.004551:0.004188:0.002464:0.009223:0.009903:0.009223:0.005020
valved implants and two valved implants. They differ in :@0.076190:0.273459:0.485115:0.273459:0.485115:0.257676:0.076190:0.257676:0.008376:0.010326:0.003024:0.008376:0.009827:0.010357:0.004657:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866:0.004657:0.010326:0.009223:0.010357:0.004657:0.005125:0.012564:0.009903:0.004642:0.008376:0.010326:0.003024:0.008376:0.009827:0.010357:0.004657:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866:0.004188:0.004657:0.006441:0.009223:0.009827:0.008104:0.004642:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.004657:0.003024:0.009223:0.004188
their type and features, including whether they are for :@0.076190:0.287764:0.485145:0.287764:0.485145:0.271981:0.076190:0.271981:0.005125:0.009223:0.009827:0.003024:0.004551:0.005322:0.005125:0.008104:0.010311:0.009827:0.005322:0.010326:0.009223:0.010357:0.005322:0.004747:0.009827:0.010326:0.005125:0.009192:0.004551:0.009827:0.005866:0.004188:0.005307:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.005322:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.005307:0.005125:0.009223:0.009827:0.008104:0.005322:0.010326:0.004551:0.009827:0.005322:0.004747:0.009903:0.004551:0.004188
paediatric use, whether the tube can be placed in the :@0.076190:0.302069:0.485130:0.302069:0.485130:0.286286:0.076190:0.286286:0.010311:0.010326:0.009827:0.010357:0.003024:0.010326:0.005125:0.004551:0.003024:0.009782:0.004505:0.009192:0.005866:0.009827:0.004188:0.004505:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.004490:0.005125:0.009223:0.009827:0.004505:0.005125:0.009192:0.010311:0.009827:0.004505:0.009782:0.010326:0.009223:0.004505:0.010311:0.009827:0.004505:0.010311:0.003024:0.010326:0.009782:0.009827:0.010357:0.004505:0.003024:0.009223:0.004505:0.005125:0.009223:0.009827:0.004188
anterior  chamber  or  the  pars  plana and  in  their  foot-:@0.076190:0.316373:0.480942:0.316373:0.480942:0.300591:0.076190:0.300591:0.010326:0.009223:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.004188:0.002313:0.009782:0.009223:0.010326:0.014182:0.010311:0.009827:0.004551:0.004188:0.002313:0.009903:0.004551:0.004188:0.002313:0.005125:0.009223:0.009827:0.004188:0.002313:0.010311:0.010326:0.004551:0.005866:0.004188:0.002313:0.010311:0.003024:0.010326:0.009223:0.010326:0.006516:0.010326:0.009223:0.010357:0.004188:0.002313:0.003024:0.009223:0.004188:0.002313:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188:0.002313:0.004747:0.009903:0.009903:0.005125:0.005020
plate size and design:@0.076190:0.330678:0.230888:0.330678:0.230888:0.314896:0.076190:0.314896:0.010311:0.003024:0.010326:0.005125:0.009827:0.004188:0.005866:0.003024:0.006426:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.010357:0.009827:0.005866:0.003024:0.010175:0.009223
types of implants include: :@0.076190:0.352684:0.269109:0.352684:0.269109:0.336185:0.076190:0.336185:0.006350:0.008769:0.009979:0.009676:0.006652:0.004233:0.009676:0.004233:0.004233:0.003629:0.014212:0.009979:0.003629:0.009979:0.009071:0.004536:0.006652:0.004233:0.003629:0.009071:0.009676:0.003629:0.009071:0.009979:0.009676:0.004233:0.004233
•  Non-valved implants:@0.076190:0.366989:0.247232:0.366989:0.247232:0.351206:0.076190:0.351206:0.009162:0.004188:0.006804:0.011188:0.009903:0.009223:0.005020:0.008376:0.010326:0.003024:0.008376:0.009827:0.010357:0.004188:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866
-  Molteno (polypropylene):@0.096344:0.381293:0.299166:0.381293:0.299166:0.365511:0.096344:0.365511:0.005020:0.004188:0.010946:0.013894:0.009903:0.003024:0.005125:0.009827:0.009223:0.009903:0.004188:0.005579:0.010311:0.009903:0.003024:0.008104:0.010311:0.004551:0.009903:0.010311:0.008104:0.003024:0.009827:0.009223:0.009827:0.005579
-  Baerfeldt (silicone):@0.096344:0.395598:0.251979:0.395598:0.251979:0.379816:0.096344:0.379816:0.005020:0.004188:0.010946:0.008678:0.010326:0.009827:0.004551:0.004747:0.009827:0.003024:0.010357:0.005125:0.004188:0.005579:0.005866:0.003024:0.003024:0.003024:0.009782:0.009903:0.009223:0.009827:0.005579
-  schocket (silicone tube and encircling band):@0.096344:0.409903:0.447242:0.409903:0.447242:0.394120:0.096344:0.394120:0.005020:0.004188:0.010946:0.007529:0.009782:0.009223:0.009903:0.009782:0.007590:0.009827:0.005125:0.004188:0.005579:0.005866:0.003024:0.003024:0.003024:0.009782:0.009903:0.009223:0.009827:0.004188:0.005125:0.009192:0.010311:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.009827:0.009223:0.009782:0.003024:0.004551:0.009782:0.003024:0.003024:0.009223:0.010175:0.004188:0.010311:0.010326:0.009223:0.010357:0.005579
-  Express (titanium implant):@0.096344:0.424208:0.302250:0.424208:0.302250:0.408425:0.096344:0.408425:0.005020:0.004188:0.010946:0.008104:0.007257:0.010311:0.004551:0.009827:0.005866:0.005866:0.004188:0.005579:0.005125:0.003024:0.005125:0.010326:0.009223:0.003024:0.009192:0.014182:0.004188:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005579
•  Valved implants:@0.076175:0.438513:0.214121:0.438513:0.214121:0.422730:0.076175:0.422730:0.009162:0.004188:0.006804:0.010614:0.010326:0.003024:0.008376:0.009827:0.010357:0.004188:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.005866
-  Krupin (silicone):@0.096329:0.452817:0.230737:0.452817:0.230737:0.437035:0.096329:0.437035:0.005020:0.004188:0.010946:0.008935:0.004551:0.009192:0.010311:0.003024:0.009223:0.004188:0.005579:0.005866:0.003024:0.003024:0.003024:0.009782:0.009903:0.009223:0.009827:0.005579
-  Ahmed (polypropylene and silicone):@0.096329:0.467122:0.384982:0.467122:0.384982:0.451340:0.096329:0.451340:0.005020:0.004188:0.010946:0.011188:0.009223:0.014182:0.009827:0.010357:0.004188:0.005579:0.010311:0.009903:0.003024:0.008104:0.010311:0.004551:0.009903:0.010311:0.008104:0.003024:0.009827:0.009223:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.003024:0.003024:0.003024:0.009782:0.009903:0.009223:0.009827:0.005579
After the implant, there is an initial hypotensive phase, :@0.090448:0.481427:0.485100:0.481427:0.485100:0.465644:0.090448:0.465644:0.011188:0.004747:0.005125:0.009827:0.004551:0.003629:0.005125:0.009223:0.009827:0.003644:0.003024:0.014182:0.010311:0.003024:0.010326:0.009223:0.005125:0.004188:0.003644:0.005125:0.009223:0.009827:0.004551:0.009827:0.003629:0.003024:0.005866:0.003644:0.010326:0.009223:0.003644:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003659:0.009223:0.008104:0.010311:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.003644:0.010311:0.009223:0.010326:0.005866:0.009827:0.004188:0.004188
then  a hypertensive phase where  the  bleb becomes :@0.076160:0.495732:0.485100:0.495732:0.485100:0.479949:0.076160:0.479949:0.005125:0.009223:0.009827:0.009223:0.004188:0.002782:0.010326:0.006985:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.006985:0.010311:0.009223:0.010326:0.005866:0.009827:0.006985:0.012564:0.009223:0.009827:0.004551:0.009827:0.004188:0.002782:0.005125:0.009223:0.009827:0.004188:0.002782:0.010311:0.003024:0.009827:0.010311:0.006985:0.010311:0.009827:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188
encapsulated and, lastly, the stable phase. The attrition :@0.076160:0.510037:0.485115:0.510037:0.485115:0.494254:0.076160:0.494254:0.009827:0.009223:0.009782:0.010326:0.010311:0.005866:0.009192:0.003024:0.010326:0.005125:0.009827:0.010357:0.004082:0.010326:0.009223:0.010357:0.004188:0.004067:0.003024:0.010326:0.005866:0.005125:0.003024:0.008104:0.004188:0.004082:0.005125:0.009223:0.009827:0.004067:0.005866:0.005125:0.010326:0.010311:0.003024:0.009827:0.004082:0.010311:0.009223:0.010326:0.005866:0.009827:0.004188:0.004067:0.006441:0.009223:0.009827:0.004067:0.010326:0.005125:0.005125:0.004551:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188
rate for glaucoma-drainage devices is 10% per year.:@0.076160:0.524342:0.460350:0.524342:0.460350:0.508559:0.076160:0.508559:0.004551:0.010326:0.005125:0.009827:0.004188:0.004747:0.009903:0.004551:0.004188:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005020:0.010357:0.004551:0.010326:0.003024:0.009223:0.010326:0.010175:0.009827:0.004188:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.005866:0.004188:0.003024:0.005866:0.004188:0.008376:0.008376:0.011717:0.004188:0.010311:0.009827:0.004551:0.004188:0.008104:0.009827:0.010326:0.004551:0.004188
Complications of glaucoma-drainage devices are :@0.090448:0.538646:0.485115:0.538646:0.485115:0.522864:0.090448:0.522864:0.012292:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.009585:0.009903:0.004747:0.009585:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005020:0.010357:0.004551:0.010326:0.003024:0.009223:0.010326:0.010175:0.009827:0.009585:0.010357:0.009827:0.008376:0.003024:0.009782:0.009827:0.005866:0.009585:0.010326:0.004551:0.009827:0.004188
early hypotony and choroidal detachment,  tube ob-:@0.076160:0.552951:0.480912:0.552951:0.480912:0.537169:0.076160:0.537169:0.009827:0.010326:0.004551:0.003024:0.008104:0.007030:0.009223:0.008104:0.010311:0.009903:0.005125:0.009903:0.009223:0.008089:0.007030:0.010326:0.009223:0.010357:0.007030:0.009782:0.009223:0.009903:0.004551:0.009903:0.003024:0.010357:0.010326:0.003024:0.007030:0.010357:0.009827:0.005125:0.010326:0.009782:0.009223:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188:0.002827:0.005125:0.009192:0.010311:0.009827:0.007030:0.009903:0.010311:0.005020
struction,  overhanging bleb, exposed tube and en-:@0.076160:0.567256:0.480927:0.567256:0.480927:0.551473:0.076160:0.551473:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.005020:0.009903:0.008376:0.009827:0.004551:0.009223:0.010326:0.009223:0.010175:0.003024:0.009223:0.010175:0.009223:0.010311:0.003024:0.009827:0.010311:0.004188:0.009223:0.009827:0.007257:0.010311:0.009903:0.005866:0.009827:0.010357:0.009223:0.005125:0.009192:0.010311:0.009827:0.009223:0.010326:0.009223:0.010357:0.009223:0.009827:0.009223:0.005020
dophthalmitis.:@0.076160:0.581561:0.179060:0.581561:0.179060:0.565778:0.076160:0.565778:0.010357:0.009903:0.010311:0.009223:0.005125:0.009223:0.010326:0.003024:0.014182:0.003024:0.005125:0.003024:0.005866:0.004188
WHO tO refer:@0.076190:0.614588:0.204064:0.614588:0.204064:0.594423:0.076190:0.594423:0.016631:0.012566:0.015522:0.005174:0.007761:0.015522:0.005174:0.010718:0.009609:0.008870:0.009609:0.010718
Neonates or infants, if there is a larger-than-normal eye, :@0.076190:0.630670:0.485145:0.630670:0.485145:0.614888:0.076190:0.614888:0.011188:0.009827:0.009903:0.009223:0.010326:0.005125:0.009827:0.005866:0.004022:0.009903:0.004551:0.004022:0.003024:0.009223:0.004747:0.010326:0.009223:0.005125:0.005866:0.004188:0.004022:0.003024:0.004747:0.004037:0.005125:0.009223:0.009827:0.004551:0.009827:0.004022:0.003024:0.005866:0.004037:0.010326:0.004037:0.003024:0.010326:0.004551:0.010175:0.009827:0.004551:0.005020:0.005125:0.009223:0.010326:0.009223:0.005020:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004022:0.009827:0.008104:0.009827:0.004188:0.004188
epiphora, photophobia and a cloudy cornea. The chil-:@0.076190:0.644975:0.480957:0.644975:0.480957:0.629193:0.076190:0.629193:0.009827:0.010311:0.003024:0.010311:0.009223:0.009903:0.004551:0.010326:0.004188:0.004505:0.010311:0.009223:0.009903:0.005125:0.009903:0.010311:0.009223:0.009903:0.010311:0.003024:0.010326:0.004505:0.010326:0.009223:0.010357:0.004521:0.010326:0.004521:0.009782:0.003024:0.009903:0.009192:0.010357:0.008104:0.004521:0.009782:0.009903:0.004551:0.009223:0.009827:0.010326:0.004188:0.004505:0.006441:0.009223:0.009827:0.004505:0.009782:0.009223:0.003024:0.003024:0.005020
dren will likely need an examination under anaesthetic :@0.076190:0.659280:0.485115:0.659280:0.485115:0.643497:0.076190:0.643497:0.010357:0.004551:0.009827:0.009223:0.004778:0.012564:0.003024:0.003024:0.003024:0.004793:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.004793:0.009223:0.009827:0.009827:0.010357:0.004793:0.010326:0.009223:0.004793:0.009827:0.007257:0.010326:0.014182:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004778:0.009192:0.009223:0.010357:0.009827:0.004551:0.004778:0.010326:0.009223:0.010326:0.009827:0.005866:0.005125:0.009223:0.009827:0.005125:0.003024:0.009782:0.004188
and will have follow-on surgery at the time of the exami-:@0.076190:0.673585:0.480927:0.673585:0.480927:0.657802:0.076190:0.657802:0.010326:0.009223:0.010357:0.003568:0.012564:0.003024:0.003024:0.003024:0.003568:0.009223:0.010326:0.008376:0.009827:0.003568:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.005020:0.009903:0.009223:0.003553:0.005866:0.009192:0.004551:0.010175:0.009827:0.004551:0.008104:0.003553:0.010326:0.005125:0.003568:0.005125:0.009223:0.009827:0.003553:0.005125:0.003024:0.014182:0.009827:0.003568:0.009903:0.004747:0.003568:0.005125:0.009223:0.009827:0.003553:0.009827:0.007257:0.010326:0.014182:0.003024:0.005020
nation.:@0.076190:0.687890:0.127202:0.687890:0.127202:0.672107:0.076190:0.672107:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
Children with anterior segment abnormalities, such as :@0.090478:0.702194:0.485130:0.702194:0.485130:0.686412:0.090478:0.686412:0.012292:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.010326:0.009223:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.004173:0.005866:0.009827:0.010175:0.014182:0.009827:0.009223:0.005125:0.004173:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.004188:0.004188:0.005866:0.009192:0.009782:0.009223:0.004188:0.010326:0.005866:0.004188
polycoria, pseudopolycoria and pseudogerontoxon, :@0.076190:0.716499:0.485175:0.716499:0.485175:0.700717:0.076190:0.700717:0.010311:0.009903:0.003024:0.008104:0.009782:0.009903:0.004551:0.003024:0.010326:0.004188:0.010886:0.010311:0.005866:0.009827:0.009192:0.010357:0.009903:0.010311:0.009903:0.003024:0.008104:0.009782:0.009903:0.004551:0.003024:0.010326:0.010886:0.010326:0.009223:0.010357:0.010886:0.010311:0.005866:0.009827:0.009192:0.010357:0.009903:0.010175:0.009827:0.004551:0.009903:0.009223:0.005125:0.009903:0.007257:0.009903:0.009223:0.004188:0.004188
are at risk of glaucoma. :@0.076190:0.730804:0.254066:0.730804:0.254066:0.715021:0.076190:0.715021:0.010326:0.004551:0.009827:0.004188:0.010326:0.005125:0.004188:0.004551:0.003024:0.005866:0.007590:0.004188:0.009903:0.004747:0.004188:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188
Children  with  sturge  Weber  syndrome  will need :@0.090478:0.745109:0.485130:0.745109:0.485130:0.729326:0.090478:0.729326:0.012292:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.004188:0.007590:0.012564:0.003024:0.005125:0.009223:0.004188:0.007605:0.007529:0.005125:0.009192:0.004551:0.010175:0.009827:0.004188:0.007590:0.014514:0.009827:0.010311:0.009827:0.004551:0.004188:0.007590:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188:0.007590:0.012564:0.003024:0.003024:0.003024:0.011793:0.009223:0.009827:0.009827:0.010357:0.004188
screening as they have a raised episcleral venous pres-:@0.076190:0.759414:0.480927:0.759414:0.480927:0.743631:0.076190:0.743631:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.004400:0.010326:0.005866:0.004400:0.005125:0.009223:0.009827:0.008104:0.004400:0.009223:0.010326:0.008376:0.009827:0.004400:0.010326:0.004400:0.004551:0.010326:0.003024:0.005866:0.009827:0.010357:0.004400:0.009827:0.010311:0.003024:0.005866:0.009782:0.003024:0.009827:0.004551:0.010326:0.003024:0.004415:0.008376:0.009827:0.009223:0.009903:0.009192:0.005866:0.004400:0.010311:0.004551:0.009827:0.005866:0.005020
sure.:@0.076190:0.773718:0.109815:0.773718:0.109815:0.757936:0.076190:0.757936:0.005866:0.009192:0.004551:0.009827:0.004188
Black patients with a family history of glaucoma will :@0.090478:0.788023:0.485145:0.788023:0.485145:0.772241:0.090478:0.772241:0.008678:0.003024:0.010326:0.009782:0.007590:0.006199:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006199:0.012564:0.003024:0.005125:0.009223:0.006199:0.010326:0.006199:0.004747:0.010326:0.014182:0.003024:0.003024:0.008104:0.006199:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.006199:0.009903:0.004747:0.006199:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.006199:0.012564:0.003024:0.003024:0.003024:0.004188
need to be screened earlier to assess if any parameters :@0.076190:0.802328:0.485160:0.802328:0.485160:0.786545:0.076190:0.786545:0.009223:0.009827:0.009827:0.010357:0.004112:0.005125:0.009903:0.004112:0.010311:0.009827:0.004112:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.009827:0.010357:0.004112:0.009827:0.010326:0.004551:0.003024:0.003024:0.009827:0.004551:0.004112:0.005125:0.009903:0.004112:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004127:0.003024:0.004747:0.004112:0.010326:0.009223:0.008104:0.004112:0.010311:0.010326:0.004551:0.010326:0.014182:0.009827:0.005125:0.009827:0.004551:0.005866:0.004188
exceed the normal range, such as increased cup-disc :@0.076190:0.816633:0.485130:0.816633:0.485130:0.800850:0.076190:0.800850:0.009827:0.007257:0.009782:0.009827:0.009827:0.010357:0.005397:0.005125:0.009223:0.009827:0.005397:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.005413:0.004551:0.010326:0.009223:0.010175:0.009827:0.004188:0.005397:0.005866:0.009192:0.009782:0.009223:0.005397:0.010326:0.005866:0.005413:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005413:0.009782:0.009192:0.010311:0.005020:0.010357:0.003024:0.005866:0.009782:0.004188
ratio and raised intra-ocular pressure.:@0.076190:0.830938:0.347955:0.830938:0.347955:0.815155:0.076190:0.815155:0.004551:0.010326:0.005125:0.003024:0.009903:0.004188:0.010326:0.009223:0.010357:0.004188:0.004551:0.010326:0.003024:0.005866:0.009827:0.010357:0.004188:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188
patients who complain of intermittent eye pain when :@0.090478:0.845243:0.485160:0.845243:0.485160:0.829460:0.090478:0.829460:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004581:0.012564:0.009223:0.009903:0.004581:0.009782:0.009903:0.014182:0.010311:0.003024:0.010326:0.003024:0.009223:0.004581:0.009903:0.004747:0.004581:0.003024:0.009223:0.005125:0.009827:0.004551:0.014182:0.003024:0.005125:0.005125:0.009827:0.009223:0.005125:0.004566:0.009827:0.008104:0.009827:0.004581:0.010311:0.010326:0.003024:0.009223:0.004581:0.012564:0.009223:0.009827:0.009223:0.004188
watching television in the  dark,  or  when  they  see a :@0.076190:0.859547:0.485115:0.859547:0.485115:0.843765:0.076190:0.843765:0.012564:0.010326:0.005125:0.009782:0.009223:0.003024:0.009223:0.010175:0.007922:0.005125:0.009827:0.003024:0.009827:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223:0.007922:0.003024:0.009223:0.007922:0.005125:0.009223:0.009827:0.004188:0.003719:0.010357:0.010326:0.004551:0.007590:0.004188:0.004188:0.003719:0.009903:0.004551:0.004188:0.003719:0.012564:0.009223:0.009827:0.009223:0.004188:0.003719:0.005125:0.009223:0.009827:0.008104:0.004188:0.003719:0.005866:0.009827:0.009827:0.007922:0.010326:0.004188
movie, will need to be screened for intermittent angle :@0.076190:0.873852:0.485145:0.873852:0.485145:0.858069:0.076190:0.858069:0.014182:0.009903:0.008376:0.003024:0.009827:0.004188:0.005609:0.012564:0.003024:0.003024:0.003024:0.005609:0.009223:0.009827:0.009827:0.010357:0.005594:0.005125:0.009903:0.005594:0.010311:0.009827:0.005609:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.009827:0.010357:0.005609:0.004747:0.009903:0.004551:0.005594:0.003024:0.009223:0.005125:0.009827:0.004551:0.014182:0.003024:0.005125:0.005125:0.009827:0.009223:0.005125:0.005594:0.010326:0.009223:0.010175:0.003024:0.009827:0.004188
closure and should be referred if any of the parameters :@0.076190:0.888157:0.485145:0.888157:0.485145:0.872374:0.076190:0.872374:0.009782:0.003024:0.009903:0.005866:0.009192:0.004551:0.009827:0.004173:0.010326:0.009223:0.010357:0.004188:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.010311:0.009827:0.004188:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010341:0.004188:0.003024:0.004747:0.004188:0.010326:0.009223:0.008104:0.004188:0.009903:0.004747:0.004173:0.005125:0.009223:0.009827:0.004173:0.010311:0.010326:0.004551:0.010326:0.014182:0.009827:0.005125:0.009827:0.004551:0.005866:0.004188
are not within normal limits.:@0.076190:0.902462:0.273721:0.902462:0.273721:0.886679:0.076190:0.886679:0.010326:0.004551:0.009827:0.004188:0.009223:0.009903:0.005125:0.004188:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004188:0.003024:0.003024:0.014182:0.003024:0.005125:0.005866:0.004188
Known glaucoma patients who have not been seen :@0.090478:0.916767:0.485130:0.916767:0.485130:0.900984:0.090478:0.900984:0.008935:0.009223:0.009903:0.012564:0.009223:0.005322:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005322:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005322:0.012564:0.009223:0.009903:0.005322:0.009223:0.010326:0.008376:0.009827:0.005322:0.009223:0.009903:0.005125:0.005322:0.010311:0.009827:0.009827:0.009223:0.005322:0.005866:0.009827:0.009827:0.009223:0.004188
or received medication within the past 12 months.:@0.076190:0.931071:0.442751:0.931071:0.442751:0.915289:0.076190:0.915289:0.009903:0.004551:0.004188:0.004551:0.009827:0.009782:0.009827:0.003024:0.008376:0.009827:0.010357:0.004188:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.010326:0.005866:0.005125:0.004188:0.008376:0.008376:0.004188:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188
Known glaucoma patients who have new complaints :@0.090478:0.945376:0.485130:0.945376:0.485130:0.929594:0.090478:0.929594:0.008935:0.009223:0.009903:0.012564:0.009223:0.003840:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.003840:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003855:0.012564:0.009223:0.009903:0.003840:0.009223:0.010326:0.008376:0.009827:0.003840:0.009223:0.009827:0.012564:0.003840:0.009782:0.009903:0.014182:0.010311:0.003024:0.010326:0.003024:0.009223:0.005125:0.005866:0.004188
related to glaucoma or associated with the treatment :@0.519042:0.084940:0.927982:0.084940:0.927982:0.069157:0.519042:0.069157:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.005352:0.005125:0.009903:0.005352:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005352:0.009903:0.004551:0.005352:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.005367:0.012564:0.003024:0.005125:0.009223:0.005367:0.005125:0.009223:0.009827:0.005352:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188
of their glaucoma.:@0.519042:0.099707:0.654917:0.099707:0.654917:0.083924:0.519042:0.083924:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188
The  section on diagnostic issues mentions  the  para-:@0.533330:0.114473:0.923794:0.114473:0.923794:0.098691:0.533330:0.098691:0.006441:0.009223:0.009827:0.004188:0.002313:0.005866:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.006516:0.009903:0.009223:0.006516:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.006516:0.003024:0.005866:0.005866:0.009192:0.009827:0.005866:0.006516:0.014182:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.002313:0.005125:0.009223:0.009827:0.004188:0.002313:0.010311:0.010326:0.004551:0.010326:0.005020
meters that are measured.:@0.519042:0.129240:0.713806:0.129240:0.713806:0.113457:0.519042:0.113457:0.014182:0.009827:0.005125:0.009827:0.004551:0.005866:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.010326:0.004551:0.009827:0.004188:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.010357:0.004188
summAry:@0.519047:0.162745:0.609594:0.162745:0.609594:0.142580:0.519047:0.142580:0.009609:0.011826:0.016631:0.016631:0.013674:0.010718:0.011457
The  mainstay of  treatment  is  to  decrease  intra-ocular :@0.519047:0.179289:0.927987:0.179289:0.927987:0.163506:0.519047:0.163506:0.006441:0.009223:0.009827:0.004188:0.002495:0.014182:0.010326:0.003024:0.009223:0.005866:0.005125:0.010326:0.008104:0.006698:0.009903:0.004747:0.004188:0.002495:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.002495:0.003024:0.005866:0.004188:0.002495:0.005125:0.009903:0.004188:0.002495:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004188:0.002495:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188
pressure as it is the only modifiable variant. Traditionally, :@0.519047:0.194056:0.928002:0.194056:0.928002:0.178273:0.519047:0.178273:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004127:0.010326:0.005866:0.004127:0.003024:0.005125:0.004127:0.003024:0.005866:0.004127:0.005125:0.009223:0.009827:0.004127:0.009903:0.009223:0.003024:0.008104:0.004127:0.014182:0.009903:0.010357:0.003024:0.003681:0.003681:0.010326:0.010311:0.003024:0.009827:0.004127:0.008376:0.010326:0.004551:0.003024:0.010326:0.009223:0.005125:0.004188:0.004127:0.006441:0.004551:0.010326:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003024:0.008104:0.004188:0.004188
medical therapy is the starting point, but clinicians have :@0.519047:0.208822:0.927972:0.208822:0.927972:0.193040:0.519047:0.193040:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.003734:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003719:0.003024:0.005866:0.003734:0.005125:0.009223:0.009827:0.003719:0.005866:0.005125:0.010326:0.004551:0.005125:0.003024:0.009223:0.010175:0.003719:0.010311:0.009903:0.003024:0.009223:0.005125:0.004188:0.003719:0.010311:0.009192:0.005125:0.003734:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.003024:0.010326:0.009223:0.005866:0.003734:0.009223:0.010326:0.008376:0.009827:0.004188
been tailoring a patient-specific approach and modify:@0.519047:0.223589:0.918780:0.223589:0.918780:0.207806:0.519047:0.207806:0.010311:0.009827:0.009827:0.009223:0.003825:0.005125:0.010326:0.003024:0.003024:0.009903:0.004551:0.003024:0.009223:0.010175:0.003825:0.010326:0.003825:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005020:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.003825:0.010326:0.010311:0.010311:0.004551:0.009903:0.010326:0.009782:0.009223:0.003825:0.010326:0.009223:0.010357:0.003825:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104
-:@0.918780:0.223589:0.923799:0.223589:0.923799:0.207806:0.918780:0.207806:0.005020
ing the treatment according to the type of glaucoma, :@0.519047:0.238356:0.928002:0.238356:0.928002:0.222573:0.519047:0.222573:0.003024:0.009223:0.010175:0.004929:0.005125:0.009223:0.009827:0.004929:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004914:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.004929:0.005125:0.009903:0.004929:0.005125:0.009223:0.009827:0.004929:0.005125:0.008104:0.010311:0.009827:0.004929:0.009903:0.004747:0.004929:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188
the resources available, patients’ access to medication :@0.519047:0.253122:0.928002:0.253122:0.928002:0.237340:0.519047:0.237340:0.005125:0.009223:0.009827:0.003840:0.004551:0.009827:0.005866:0.009903:0.009192:0.004551:0.009782:0.009827:0.005866:0.003840:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.003855:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005307:0.003855:0.010326:0.009782:0.009782:0.009827:0.005866:0.005866:0.003855:0.005125:0.009903:0.003840:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
and follow-up, patient ethnicity in terms of prognostic :@0.519047:0.267889:0.928032:0.267889:0.928032:0.252106:0.519047:0.252106:0.010326:0.009223:0.010357:0.006184:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.005020:0.009192:0.010311:0.004188:0.006184:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.006184:0.009827:0.005125:0.009223:0.009223:0.003024:0.009782:0.003024:0.005125:0.008104:0.006184:0.003024:0.009223:0.006184:0.005125:0.009827:0.004551:0.014182:0.005866:0.006184:0.009903:0.004747:0.006184:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.004188
factors, as well as the degree of advancement of the :@0.519047:0.282655:0.927972:0.282655:0.927972:0.266873:0.519047:0.266873:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.005624:0.010326:0.005866:0.005639:0.012564:0.009827:0.003024:0.003024:0.005624:0.010326:0.005866:0.005639:0.005125:0.009223:0.009827:0.005624:0.010357:0.009827:0.010175:0.004551:0.009827:0.009812:0.005624:0.009903:0.004747:0.005624:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.005624:0.009903:0.004747:0.005624:0.005125:0.009223:0.009827:0.004188
glaucoma.:@0.519047:0.297422:0.600146:0.297422:0.600146:0.281639:0.519047:0.281639:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188
referenCes:@0.519047:0.330935:0.625485:0.330935:0.625485:0.310770:0.519047:0.310770:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1. :@0.519047:0.343485:0.532077:0.343485:0.532077:0.331209:0.519047:0.331209:0.006515:0.003257:0.003257
Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and :@0.544247:0.343485:0.927058:0.343485:0.927058:0.331209:0.544247:0.331209:0.005703:0.007702:0.004563:0.003986:0.007644:0.003540:0.003657:0.006961:0.005668:0.003257:0.003657:0.006750:0.007150:0.007173:0.003540:0.011030:0.008032:0.007173:0.007173:0.003657:0.007138:0.003257:0.003657:0.010242:0.007150:0.002352:0.007914:0.002352:0.007644:0.006303:0.003669:0.008032:0.008702:0.003257:0.003657:0.005668:0.007702:0.007173:0.007173:0.004563:0.007702:0.007173:0.003657:0.010254:0.005668:0.003257:0.003657:0.005009:0.007173:0.007644:0.003657:0.008055:0.007644:0.002863:0.002863:0.007173:0.002352:0.003986:0.002352:0.007702:0.007173:0.003657:0.008032:0.007173:0.008055:0.003257
classification of glaucoma in prevalence surveys:@0.544247:0.355042:0.822118:0.355042:0.822118:0.342766:0.544247:0.342766:0.007608:0.002352:0.008032:0.004563:0.004563:0.002352:0.002863:0.002863:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.003728:0.007702:0.003692:0.003728:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003728:0.002352:0.007173:0.003728:0.008020:0.003540:0.007644:0.006515:0.008032:0.002352:0.007644:0.007173:0.007608:0.007644:0.003728:0.004563:0.007150:0.003540:0.006515:0.007644:0.006303:0.004563
. Br J Ophthalmol:@0.822118:0.355042:0.920555:0.355042:0.920555:0.342766:0.822118:0.342766:0.003257:0.003728:0.006750:0.003540:0.003728:0.005668:0.003728:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352
. :@0.920555:0.355042:0.927070:0.355042:0.927070:0.342766:0.920555:0.342766:0.003257:0.003257
2002; 86:238-242.:@0.544247:0.366599:0.639356:0.366599:0.639356:0.354323:0.544247:0.354323:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
2. :@0.519047:0.378155:0.532077:0.378155:0.532077:0.365880:0.519047:0.365880:0.006515:0.003257:0.003257
Labuschagne MJ. Glaucoma: What should the general practitioner :@0.544247:0.378155:0.927082:0.378155:0.927082:0.365880:0.544247:0.365880:0.005433:0.008032:0.008020:0.007150:0.004563:0.007608:0.007173:0.008032:0.007914:0.007173:0.007644:0.002740:0.010807:0.005668:0.003257:0.002740:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257:0.002740:0.011289:0.007173:0.008032:0.003986:0.002740:0.004563:0.007173:0.007702:0.007150:0.002352:0.008055:0.002740:0.003986:0.007173:0.007644:0.002740:0.007914:0.007644:0.007173:0.007644:0.003540:0.008032:0.002352:0.002740:0.008020:0.003540:0.008032:0.007608:0.003986:0.002352:0.003986:0.002352:0.007702:0.007173:0.007644:0.003540:0.003257
know? :@0.544247:0.389712:0.585005:0.389712:0.585005:0.377437:0.544247:0.377437:0.005903:0.007173:0.007702:0.009772:0.006950:0.003257
SA Fam Pract:@0.584993:0.389712:0.660958:0.389712:0.660958:0.377437:0.584993:0.377437:0.005856:0.008702:0.003257:0.005703:0.008032:0.011030:0.003257:0.006961:0.003540:0.008032:0.007608:0.003986
. 2010; 52(6):493-497.:@0.660946:0.389712:0.777763:0.389712:0.777763:0.377437:0.660946:0.377437:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
3. :@0.519047:0.401269:0.532077:0.401269:0.532077:0.388994:0.519047:0.388994:0.006515:0.003257:0.003257
Bordeianu C. Critical analysis of the classification of glaucomas is:@0.544247:0.401269:0.919885:0.401269:0.919885:0.388994:0.544247:0.388994:0.006750:0.007702:0.003540:0.008055:0.007644:0.002352:0.008032:0.007173:0.007150:0.004033:0.009560:0.003257:0.004033:0.009560:0.003540:0.002352:0.003986:0.002352:0.007608:0.008032:0.002352:0.004045:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.004045:0.007702:0.003692:0.004033:0.003986:0.007173:0.007644:0.004033:0.007608:0.002352:0.008032:0.004563:0.004563:0.002352:0.002863:0.002863:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.004045:0.007702:0.003692:0.004033:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.004563:0.004033:0.002352:0.004563
-:@0.919885:0.401269:0.923789:0.401269:0.923789:0.388994:0.919885:0.388994:0.003904
sued by the European Glaucoma society in 2008. :@0.544247:0.412826:0.828116:0.412826:0.828116:0.400551:0.544247:0.400551:0.004563:0.007150:0.007644:0.008055:0.003151:0.008020:0.006303:0.003151:0.003986:0.007173:0.007644:0.003151:0.006303:0.007150:0.003540:0.007702:0.008020:0.007644:0.008032:0.007173:0.003151:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003151:0.005856:0.007702:0.007608:0.002352:0.007644:0.003986:0.006303:0.003151:0.002352:0.007173:0.003151:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
Clinical Ophthal-:@0.828010:0.412826:0.923812:0.412826:0.923812:0.400551:0.828010:0.400551:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003163:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.003904
mology.:@0.544247:0.424383:0.590508:0.424383:0.590508:0.412108:0.544247:0.412108:0.011030:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257
 2014;8:271-282.:@0.590508:0.424383:0.679102:0.424383:0.679102:0.412108:0.590508:0.412108:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
4. :@0.519047:0.435940:0.532077:0.435940:0.532077:0.423665:0.519047:0.423665:0.006515:0.003257:0.003257
Kyari F, Abdull MM, Bastawrous A, Gilbert C, Faal H. Epidemiology :@0.544247:0.435940:0.927035:0.435940:0.927035:0.423665:0.544247:0.423665:0.006950:0.006303:0.008032:0.003540:0.002352:0.004175:0.005703:0.003257:0.004175:0.008702:0.008020:0.008055:0.007150:0.002352:0.002352:0.004175:0.010807:0.010807:0.003257:0.004175:0.006750:0.008032:0.004563:0.003986:0.008032:0.009772:0.003540:0.007702:0.007150:0.004563:0.004175:0.008702:0.003257:0.004175:0.010254:0.002352:0.002352:0.008020:0.007644:0.003540:0.003986:0.004175:0.009560:0.003257:0.004175:0.005703:0.008032:0.008032:0.002352:0.004175:0.008032:0.003257:0.004175:0.006303:0.008020:0.002352:0.008055:0.007644:0.011030:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257
of glaucoma in sub-saharan Africa: prevalence, incidence and risk :@0.544247:0.447497:0.927058:0.447497:0.927058:0.435222:0.544247:0.435222:0.007702:0.003692:0.003069:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003069:0.002352:0.007173:0.003069:0.004563:0.007150:0.008020:0.003904:0.005856:0.008032:0.007173:0.008032:0.003540:0.008032:0.007173:0.003069:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.003257:0.003081:0.006961:0.003540:0.007644:0.006515:0.008032:0.002352:0.007644:0.007173:0.007608:0.007644:0.003257:0.003069:0.002352:0.007173:0.007608:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.003069:0.008032:0.007173:0.008055:0.003069:0.003540:0.002352:0.004563:0.005903:0.003257
factors. :@0.544247:0.459054:0.589885:0.459054:0.589885:0.446779:0.544247:0.446779:0.003692:0.008032:0.007608:0.003986:0.007702:0.003540:0.004563:0.003257:0.003257
Middle East Afr J Ophthalmol.:@0.589873:0.459054:0.757948:0.459054:0.757948:0.446779:0.589873:0.446779:0.010807:0.002352:0.008055:0.008055:0.002352:0.007644:0.003257:0.006303:0.008032:0.004563:0.003986:0.003257:0.008702:0.003692:0.003540:0.003257:0.005668:0.003257:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.003257
 2013 Apr-Jun; 20(2):111-125.:@0.757936:0.459054:0.918909:0.459054:0.918909:0.446779:0.757936:0.446779:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.008702:0.008020:0.003540:0.003904:0.005668:0.007150:0.007173:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
5. :@0.519036:0.470611:0.532065:0.470611:0.532065:0.458336:0.519036:0.458336:0.006515:0.003257:0.003257
Ramulu p. Glaucoma and disability: Which tasks are affected, and :@0.544236:0.470611:0.927035:0.470611:0.927035:0.458336:0.544236:0.458336:0.007138:0.008032:0.011030:0.007150:0.002352:0.007150:0.003410:0.006961:0.003257:0.003410:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003410:0.008032:0.007173:0.008055:0.003410:0.008055:0.002352:0.004563:0.008032:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.003257:0.003422:0.011289:0.007173:0.002352:0.007608:0.007173:0.003410:0.003986:0.008032:0.004563:0.005903:0.004563:0.003410:0.008032:0.003540:0.007644:0.003410:0.008032:0.003692:0.003692:0.007644:0.007608:0.003986:0.007644:0.008055:0.003257:0.003410:0.008032:0.007173:0.008055:0.003257
at  what  stage  of  disease? :@0.544236:0.482168:0.706643:0.482168:0.706643:0.469893:0.544236:0.469893:0.008032:0.003986:0.003257:0.002952:0.009772:0.007173:0.008032:0.003986:0.003257:0.002952:0.004563:0.003986:0.008032:0.007914:0.007644:0.003257:0.002952:0.007702:0.003692:0.003257:0.002952:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.006950:0.003257
Curr  Opin Ophthalmol:@0.709618:0.482168:0.841639:0.482168:0.841639:0.469893:0.709618:0.469893:0.009560:0.007150:0.003540:0.003540:0.003257:0.002952:0.010219:0.008020:0.002352:0.007173:0.006221:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352
 :@0.767379:0.482168:0.770636:0.482168:0.770636:0.469893:0.767379:0.469893:0.003257
.  2009 March; :@0.841639:0.482168:0.927058:0.482168:0.927058:0.469893:0.841639:0.469893:0.003257:0.003257:0.002952:0.006515:0.006515:0.006515:0.006515:0.006221:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.003257
20(2):92-98.:@0.544236:0.493725:0.608935:0.493725:0.608935:0.481450:0.544236:0.481450:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
6. :@0.519036:0.505282:0.532065:0.505282:0.532065:0.493007:0.519036:0.493007:0.006515:0.003257:0.003257
Nelson p, Aspinall p, papasouliotis O, Worton B, O’Brien C. Quality of :@0.544236:0.505282:0.927046:0.505282:0.927046:0.493007:0.544236:0.493007:0.008702:0.007644:0.002352:0.004563:0.007702:0.007173:0.002940:0.006961:0.003257:0.002940:0.008702:0.004563:0.008020:0.002352:0.007173:0.008032:0.002352:0.002352:0.002952:0.006961:0.003257:0.002940:0.006961:0.008032:0.008020:0.008032:0.004563:0.007702:0.007150:0.002352:0.002352:0.007702:0.003986:0.002352:0.004563:0.002952:0.010219:0.003257:0.002940:0.011289:0.007702:0.003540:0.003986:0.007702:0.007173:0.002928:0.006750:0.003257:0.002940:0.010219:0.004127:0.006750:0.003540:0.002352:0.007644:0.007173:0.002940:0.009560:0.003257:0.002940:0.010242:0.007150:0.008032:0.002352:0.002352:0.003986:0.006303:0.002952:0.007702:0.003692:0.003257
life in glaucoma and its relationship with visual function. :@0.544236:0.516839:0.866474:0.516839:0.866474:0.504564:0.544236:0.504564:0.002352:0.002352:0.003692:0.007644:0.003775:0.002352:0.007173:0.003775:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003775:0.008032:0.007173:0.008055:0.003775:0.002352:0.003986:0.004563:0.003775:0.003540:0.007644:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.007173:0.002352:0.008020:0.003775:0.009772:0.002352:0.003986:0.007173:0.003775:0.006515:0.002352:0.004563:0.007150:0.008032:0.002352:0.003786:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Journal of :@0.866992:0.516839:0.927035:0.516839:0.927035:0.504564:0.866992:0.504564:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.003775:0.007702:0.003692:0.003257
Glaucoma.:@0.544236:0.528396:0.609652:0.528396:0.609652:0.516121:0.544236:0.516121:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257
 2003; 12:139-150.:@0.609652:0.528396:0.708018:0.528396:0.708018:0.516121:0.609652:0.516121:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
7. :@0.519036:0.539953:0.532065:0.539953:0.532065:0.527678:0.519036:0.527678:0.006515:0.003257:0.003257
International Council of Ophthalmology: :@0.544236:0.539953:0.779103:0.539953:0.779103:0.527678:0.544236:0.527678:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003763:0.009560:0.007702:0.007150:0.007173:0.007608:0.002352:0.002352:0.003775:0.007702:0.003692:0.003763:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.003257
Guidelines for Glaucoma :@0.779621:0.539953:0.927046:0.539953:0.927046:0.527678:0.779621:0.527678:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003775:0.003692:0.007702:0.003540:0.003763:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257
Eye Care.:@0.544236:0.551510:0.599775:0.551510:0.599775:0.539235:0.544236:0.539235:0.006303:0.006303:0.007644:0.003257:0.009560:0.008032:0.003540:0.007644:0.003257
 2015:@0.599775:0.551510:0.629090:0.551510:0.629090:0.539235:0.599775:0.539235:0.003257:0.006515:0.006515:0.006515:0.006515
8. :@0.519036:0.563067:0.532065:0.563067:0.532065:0.550792:0.519036:0.550792:0.006515:0.003257:0.003257
Agarwal R, Gupta sK, Agarwal p, saxena R, Agrawal ss. Current :@0.544236:0.563067:0.927070:0.563067:0.927070:0.550792:0.544236:0.550792:0.008702:0.007914:0.008032:0.003540:0.009772:0.008032:0.002352:0.005009:0.007138:0.003257:0.005009:0.010254:0.007150:0.008020:0.003986:0.008032:0.005009:0.005856:0.006950:0.003257:0.005009:0.008702:0.007914:0.008032:0.003540:0.009772:0.008032:0.002352:0.005009:0.006961:0.003257:0.005009:0.005856:0.008032:0.005644:0.007644:0.007173:0.008032:0.005009:0.007138:0.003257:0.005009:0.008702:0.007914:0.003540:0.008032:0.009772:0.008032:0.002352:0.005009:0.005856:0.005856:0.003257:0.005009:0.009560:0.007150:0.003540:0.003540:0.007644:0.007173:0.003986:0.003257
concepts in the pathophysiology of glaucoma. :@0.544236:0.574624:0.821883:0.574624:0.821883:0.562349:0.544236:0.562349:0.007608:0.007702:0.007173:0.007608:0.007644:0.008020:0.003986:0.004563:0.004398:0.002352:0.007173:0.004398:0.003986:0.007173:0.007644:0.004398:0.008020:0.008032:0.003986:0.007173:0.007702:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.004398:0.007702:0.003692:0.004398:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257:0.003257
Indian J Ophthal-:@0.823024:0.574624:0.923789:0.574624:0.923789:0.562349:0.823024:0.562349:0.002658:0.007173:0.008055:0.002352:0.008032:0.007173:0.004398:0.005668:0.004398:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.003904
mol. :@0.544236:0.586181:0.571835:0.586181:0.571835:0.573906:0.544236:0.573906:0.011030:0.007702:0.002352:0.003257:0.003257
2009 Jul-Aug; 57(4):257-266.:@0.571835:0.586181:0.728233:0.586181:0.728233:0.573906:0.571835:0.573906:0.006515:0.006515:0.006515:0.006515:0.003257:0.005668:0.007150:0.002352:0.003904:0.008702:0.007150:0.007914:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
9. :@0.519036:0.597738:0.532065:0.597738:0.532065:0.585463:0.519036:0.585463:0.006515:0.003257:0.003257
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treat-:@0.544236:0.597738:0.923824:0.597738:0.923824:0.585463:0.544236:0.585463:0.011289:0.007644:0.002352:0.007173:0.003540:0.007644:0.008020:0.003798:0.007138:0.008702:0.003257:0.003798:0.008702:0.007150:0.007173:0.007914:0.003798:0.005009:0.003257:0.003798:0.010807:0.007644:0.008055:0.007644:0.002352:0.003540:0.007702:0.004563:0.003798:0.005703:0.008702:0.003257:0.003798:0.005009:0.007173:0.007644:0.003798:0.008020:0.008032:0.003986:0.007173:0.007702:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.003798:0.008032:0.007173:0.008055:0.003798:0.003986:0.003540:0.007644:0.008032:0.003986:0.003904
ment of glaucoma: A review. :@0.544236:0.609295:0.714251:0.609295:0.714251:0.597020:0.544236:0.597020:0.011030:0.007644:0.007173:0.003986:0.003257:0.007702:0.003692:0.003257:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257:0.003257:0.008702:0.003257:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
JAMA:@0.714227:0.609295:0.748106:0.609295:0.748106:0.597020:0.714227:0.597020:0.005668:0.008702:0.010807:0.008702
 2014. May; 311(18):1901-1911.:@0.748094:0.609295:0.919367:0.609295:0.919367:0.597020:0.748094:0.597020:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.010807:0.008032:0.006303:0.003257:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
10.  Yee s. Glaucoma therapy: Finding the right combination. :@0.519036:0.620852:0.869108:0.620852:0.869108:0.608577:0.519036:0.608577:0.006515:0.006515:0.003257:0.003257:0.005656:0.006961:0.007644:0.007644:0.002752:0.005856:0.003257:0.002752:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.002752:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.002752:0.005703:0.002352:0.007173:0.008055:0.002352:0.007173:0.007914:0.002752:0.003986:0.007173:0.007644:0.002752:0.003540:0.002352:0.007914:0.007173:0.003986:0.002752:0.007608:0.007702:0.011030:0.008020:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Review of :@0.868603:0.620852:0.927070:0.620852:0.927070:0.608577:0.868603:0.608577:0.007138:0.007644:0.006515:0.002352:0.007644:0.009772:0.002752:0.007702:0.003692:0.003257
Optometry.:@0.544236:0.632409:0.609923:0.632409:0.609923:0.620134:0.544236:0.620134:0.010219:0.008020:0.003986:0.007702:0.011030:0.007644:0.003986:0.003540:0.006303:0.003257
 2017;46-52.:@0.609911:0.632409:0.675704:0.632409:0.675704:0.620134:0.609911:0.620134:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
11.  European Glaucoma society Terminology and Guidelines for Glau-:@0.519036:0.643966:0.923777:0.643966:0.923777:0.631691:0.519036:0.631691:0.006515:0.006515:0.003257:0.003257:0.005656:0.006303:0.007150:0.003540:0.007702:0.008020:0.007644:0.008032:0.007173:0.003175:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003175:0.005856:0.007702:0.007608:0.002352:0.007644:0.003986:0.006303:0.003175:0.005009:0.007644:0.003540:0.011018:0.002352:0.007173:0.007702:0.002352:0.007702:0.007914:0.006303:0.003175:0.008032:0.007173:0.008055:0.003175:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003187:0.003692:0.007702:0.003540:0.003175:0.010254:0.002352:0.008032:0.007150:0.003904
coma, 4  Edition - Chapter 3: Treatment principles and options sup-:@0.544236:0.655523:0.923795:0.655589:0.923795:0.643314:0.544236:0.643248:0.007608:0.007702:0.011030:0.008032:0.003257:0.002928:0.006515:0.006486:0.002928:0.006303:0.008055:0.002352:0.003986:0.002352:0.007702:0.007173:0.002940:0.003904:0.002940:0.009560:0.007173:0.008032:0.008020:0.003986:0.007644:0.003540:0.002928:0.006515:0.003257:0.002940:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007161:0.003986:0.002928:0.008020:0.003540:0.002352:0.007173:0.007608:0.002352:0.008020:0.002352:0.007644:0.004563:0.002940:0.008032:0.007173:0.008055:0.002928:0.007702:0.008020:0.003986:0.002352:0.007702:0.007173:0.004563:0.002928:0.004563:0.007150:0.008020:-0.452802
th:@0.591323:0.651468:0.597795:0.651468:0.597795:0.644348:0.591323:0.644348:0.002312:0.004160
ported by the EGs Foundation. :@0.544242:0.667146:0.727087:0.667146:0.727087:0.654871:0.544242:0.654871:0.008020:0.007702:0.003540:0.003986:0.007644:0.008055:0.004198:0.008020:0.006303:0.004210:0.003986:0.007173:0.007644:0.004198:0.006303:0.010254:0.005856:0.004210:0.005703:0.007702:0.007150:0.007173:0.008055:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Br J Ophthalmol. :@0.728027:0.667146:0.826958:0.667146:0.826958:0.654871:0.728027:0.654871:0.006750:0.003540:0.004210:0.005668:0.004210:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.003257:0.003257
2017 June;101(6) :@0.827910:0.667146:0.927064:0.667146:0.927064:0.654871:0.827910:0.654871:0.006515:0.006515:0.006515:0.006515:0.004210:0.005668:0.007150:0.007173:0.007644:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257
supplementary:129-195.:@0.544242:0.678703:0.679203:0.678703:0.679203:0.666428:0.544242:0.666428:0.004563:0.007150:0.008020:0.008020:0.002352:0.007644:0.011030:0.007644:0.007173:0.003986:0.008032:0.003540:0.006303:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
12.  Meyer  JJ,  Lawrence  sD.  What  is new  in  laser  treatment  for  glau-:@0.519042:0.690260:0.923795:0.690260:0.923795:0.677985:0.519042:0.677985:0.006515:0.006515:0.003257:0.003257:0.005656:0.010807:0.007644:0.006303:0.007644:0.003540:0.003257:0.001776:0.005668:0.005668:0.003257:0.003257:0.001776:0.005433:0.008032:0.009772:0.003540:0.007644:0.007173:0.007608:0.007644:0.003257:0.001776:0.005856:0.008749:0.003257:0.003257:0.001776:0.011289:0.007173:0.008032:0.003986:0.003257:0.001776:0.002352:0.004563:0.005045:0.007173:0.007644:0.009772:0.003257:0.001776:0.002352:0.007173:0.003257:0.001776:0.002352:0.008032:0.004563:0.007644:0.003540:0.003257:0.001776:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.001776:0.003692:0.007702:0.003540:0.003257:0.001776:0.007914:0.002352:0.008032:0.007150:0.003904
coma? :@0.544242:0.701817:0.588821:0.701817:0.588821:0.689542:0.544242:0.689542:0.007608:0.007702:0.011030:0.008032:0.006950:0.003257
Current Opinion Ophthalmol. :@0.588821:0.701817:0.757473:0.701817:0.757473:0.689542:0.588821:0.689542:0.009560:0.007150:0.003540:0.003540:0.007644:0.007173:0.003986:0.003257:0.010219:0.008020:0.002352:0.007173:0.002352:0.007702:0.007173:0.003257:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.003257:0.003257
2012; 23(2):111-117.:@0.757461:0.701817:0.867763:0.701817:0.867763:0.689542:0.757461:0.689542:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
13  Richter  GM, Coleman AL.  Minimally  invasive  glaucoma surgery: :@0.519054:0.713374:0.927076:0.713374:0.927076:0.701099:0.519054:0.701099:0.006515:0.006515:0.003257:0.008914:0.007138:0.002352:0.007608:0.007173:0.003986:0.007644:0.003540:0.003257:0.002916:0.010254:0.010807:0.003257:0.006185:0.009560:0.007702:0.002352:0.007644:0.011030:0.008032:0.007173:0.006185:0.008702:0.005433:0.003257:0.003257:0.002916:0.010807:0.002352:0.007173:0.002352:0.011030:0.008032:0.002352:0.002352:0.006303:0.003257:0.002940:0.002352:0.007173:0.006515:0.008032:0.004563:0.002352:0.006515:0.007644:0.003257:0.002940:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.006185:0.004563:0.007150:0.003540:0.007914:0.007644:0.003540:0.006303:0.003257:0.003257
current status and future prospects. :@0.544254:0.724931:0.753039:0.724931:0.753039:0.712656:0.544254:0.712656:0.007608:0.007150:0.003540:0.003540:0.007644:0.007173:0.003986:0.004316:0.004563:0.003986:0.008032:0.003986:0.007150:0.004563:0.004327:0.008032:0.007173:0.008055:0.004327:0.003692:0.007150:0.003986:0.007150:0.003540:0.007644:0.004316:0.008020:0.003540:0.007702:0.004563:0.008020:0.007644:0.007608:0.003986:0.004563:0.003257:0.003257
Clinical Ophthalmology:@0.754098:0.724931:0.890176:0.724931:0.890176:0.712656:0.754098:0.712656:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.004339:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.007702:0.007914:0.006303
 :@0.795890:0.724931:0.799147:0.724931:0.799147:0.712656:0.795890:0.712656:0.003257
 2016; :@0.890176:0.724931:0.927076:0.724931:0.927076:0.712656:0.890176:0.712656:0.004327:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
10:189-206.:@0.544254:0.736488:0.606789:0.736488:0.606789:0.724213:0.544254:0.724213:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
14  pillunat LE, Erb C, Junemann AGM, Kimmich F. Micro-invasive glau-:@0.519054:0.748045:0.923807:0.748045:0.923807:0.735770:0.519054:0.735770:0.006515:0.006515:0.003257:0.008914:0.006961:0.002352:0.002352:0.002352:0.007150:0.007173:0.008032:0.003986:0.003516:0.005433:0.006303:0.003257:0.003516:0.006303:0.003540:0.008020:0.003516:0.009560:0.003257:0.003504:0.005668:0.007150:0.007173:0.007644:0.011030:0.008032:0.007173:0.007173:0.003504:0.008702:0.010254:0.010807:0.003257:0.003504:0.006950:0.002352:0.011030:0.011030:0.002352:0.007608:0.007173:0.003516:0.005703:0.003257:0.003504:0.010807:0.002352:0.007608:0.003540:0.007702:0.003904:0.002352:0.007173:0.006515:0.008032:0.004563:0.002352:0.006515:0.007644:0.003516:0.007914:0.002352:0.008032:0.007150:0.003904
coma surgery (MIGs): A review of surgical procedures using stents. :@0.544254:0.759602:0.927064:0.759602:0.927064:0.747327:0.544254:0.747327:0.007608:0.007702:0.011030:0.008032:0.003575:0.004563:0.007150:0.003540:0.007914:0.007644:0.003540:0.006303:0.003575:0.004339:0.010807:0.002658:0.010254:0.005856:0.004339:0.003257:0.003575:0.008702:0.003575:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003575:0.007702:0.003692:0.003575:0.004563:0.007150:0.003540:0.007914:0.002352:0.007608:0.008032:0.002352:0.003575:0.008020:0.003540:0.007702:0.007608:0.007644:0.008055:0.007150:0.003540:0.007644:0.004563:0.003563:0.007150:0.004563:0.002352:0.007173:0.007914:0.003575:0.004563:0.003986:0.007644:0.007173:0.003986:0.004563:0.003257:0.003257
Clinical Ophthalmology.:@0.544254:0.771159:0.682507:0.771159:0.682507:0.758884:0.544254:0.758884:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003257:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257
 2017; 11:1583-1600:@0.682507:0.771159:0.790645:0.771159:0.790645:0.758884:0.682507:0.758884:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515
15  Myers J, Masood I, Hornbeak DM, :@0.519054:0.782716:0.741915:0.782716:0.741915:0.770441:0.519054:0.770441:0.006515:0.006515:0.003257:0.008914:0.010807:0.006303:0.007644:0.003540:0.004563:0.004198:0.005668:0.003257:0.004198:0.010807:0.008032:0.004563:0.007702:0.007702:0.008055:0.004198:0.002658:0.003257:0.004198:0.008032:0.007702:0.003540:0.007173:0.008020:0.007644:0.008032:0.005903:0.004198:0.008749:0.010807:0.003257:0.003257
et al:@0.742879:0.782716:0.769091:0.782716:0.769091:0.770441:0.742879:0.770441:0.007644:0.003986:0.004198:0.008032:0.002352
. prospective evaluation of :@0.769091:0.782716:0.927088:0.782716:0.927088:0.770441:0.769091:0.770441:0.003257:0.004210:0.006961:0.003540:0.007702:0.004563:0.008020:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.004198:0.007644:0.006515:0.008032:0.002352:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.004210:0.007702:0.003692:0.003257
two isHtent trabecular stents, one istent supra suprachoroidal stent, :@0.544266:0.794273:0.927100:0.794273:0.927100:0.781998:0.544266:0.781998:0.003986:0.009772:0.007702:0.003010:0.002352:0.005856:0.008032:0.003986:0.007644:0.007173:0.003986:0.003010:0.003986:0.003540:0.008032:0.008020:0.007644:0.007608:0.007150:0.002352:0.008032:0.003540:0.003010:0.004563:0.003986:0.007644:0.007173:0.003986:0.004563:0.003257:0.002999:0.007702:0.007173:0.007644:0.002999:0.002352:0.004563:0.003986:0.007644:0.007173:0.003986:0.003010:0.004563:0.007150:0.008020:0.003540:0.008032:0.003010:0.004563:0.007150:0.008020:0.003540:0.008032:0.007608:0.007173:0.007702:0.003540:0.007702:0.002352:0.008055:0.008032:0.002352:0.003010:0.004563:0.003986:0.007644:0.007173:0.003986:0.003257:0.003257
and postoperative prostaglandin in refractory  glaucoma: 4-year :@0.544266:0.805830:0.927076:0.805830:0.927076:0.793555:0.544266:0.793555:0.008032:0.007173:0.008055:0.005597:0.008020:0.007702:0.004563:0.003986:0.007702:0.008020:0.007644:0.003540:0.008032:0.003986:0.002352:0.006515:0.007644:0.005597:0.008020:0.003540:0.007702:0.004563:0.003986:0.008032:0.007914:0.002352:0.008032:0.007173:0.008055:0.002352:0.007173:0.005597:0.002352:0.007173:0.005597:0.003540:0.007644:0.003692:0.003540:0.008032:0.007608:0.003986:0.007702:0.003540:0.006303:0.003257:0.002328:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257:0.005597:0.006515:0.003904:0.006303:0.007644:0.008032:0.003540:0.003257
outcomes. :@0.544266:0.817387:0.608165:0.817387:0.608165:0.805112:0.544266:0.805112:0.007702:0.007150:0.003986:0.007608:0.007702:0.011030:0.007644:0.004563:0.003257:0.003257
Adv. Ther:@0.608154:0.817387:0.661305:0.817387:0.661305:0.805112:0.608154:0.805112:0.008702:0.008055:0.006515:0.003257:0.003257:0.005009:0.007173:0.007644:0.003540
. 2019;35:395-407:@0.661294:0.817387:0.756402:0.817387:0.756402:0.805112:0.661294:0.805112:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515
16  Le R, Gupta N. Gold shunt for refractory  advanced low- tension :@0.519065:0.828944:0.927076:0.828944:0.927076:0.816669:0.519065:0.816669:0.006515:0.006515:0.003257:0.008914:0.005433:0.007644:0.005233:0.007138:0.003257:0.005233:0.010254:0.007150:0.008020:0.003986:0.008032:0.005233:0.008702:0.003257:0.005233:0.010254:0.007702:0.002352:0.008055:0.005233:0.004563:0.007173:0.007150:0.007173:0.003986:0.005233:0.003692:0.007702:0.003540:0.005233:0.003540:0.007644:0.003692:0.003540:0.008032:0.007608:0.003986:0.007702:0.003540:0.006303:0.003257:0.001964:0.008032:0.008055:0.006515:0.008032:0.007173:0.007608:0.007644:0.008055:0.005233:0.002352:0.007702:0.009772:0.003904:0.005233:0.003986:0.007644:0.007173:0.004563:0.002352:0.007702:0.007173:0.003257
glaucoma with spared central acuity. :@0.544266:0.840501:0.766151:0.840501:0.766151:0.828226:0.544266:0.828226:0.007914:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.004163:0.009772:0.002352:0.003986:0.007173:0.004163:0.004563:0.008020:0.008032:0.003540:0.007644:0.008055:0.004163:0.007608:0.007644:0.007173:0.003986:0.003540:0.008032:0.002352:0.004163:0.008032:0.007608:0.007150:0.002352:0.003986:0.006303:0.003257:0.003257
International Medical Case :@0.767056:0.840501:0.927076:0.840501:0.927076:0.828226:0.767056:0.828226:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.004151:0.010807:0.007644:0.008055:0.002352:0.007608:0.008032:0.002352:0.004163:0.009560:0.008032:0.004563:0.007644:0.003257
Reports Journal. :@0.544266:0.852058:0.638245:0.852058:0.638245:0.839783:0.544266:0.839783:0.007138:0.007644:0.008020:0.007702:0.003540:0.003986:0.004563:0.003257:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.003257:0.003257
2016;9:69-72:@0.638234:0.852058:0.707284:0.852058:0.707284:0.839783:0.638234:0.839783:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515
17  Heidinger A,  schwab C, Lindner  E, :@0.519065:0.863615:0.756355:0.863615:0.756355:0.851340:0.519065:0.851340:0.006515:0.006515:0.003257:0.008914:0.008032:0.007644:0.002352:0.008055:0.002352:0.007173:0.007914:0.007644:0.003540:0.006397:0.008702:0.003257:0.003257:0.003128:0.005856:0.007608:0.007173:0.009772:0.008032:0.008020:0.006397:0.009560:0.003257:0.006397:0.005433:0.002352:0.007173:0.008055:0.007173:0.007644:0.003540:0.003257:0.003128:0.006303:0.003257:0.003257
et  al:@0.759495:0.863615:0.787894:0.863615:0.787894:0.851340:0.759495:0.851340:0.007644:0.003986:0.003257:0.003128:0.008032:0.002352
. A  retrospective  study :@0.787894:0.863615:0.927076:0.863615:0.927076:0.851340:0.787894:0.851340:0.003257:0.006397:0.008702:0.003257:0.003128:0.003540:0.007644:0.003986:0.003540:0.007702:0.004563:0.008020:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.003128:0.004563:0.003986:0.007150:0.008055:0.006303:0.003257
of 199  Xen45 stent implantations  from 2014-2016. :@0.544266:0.875172:0.842692:0.875172:0.842692:0.862897:0.544266:0.862897:0.007702:0.003692:0.006644:0.006515:0.006515:0.006515:0.003257:0.003398:0.007161:0.007644:0.007173:0.006515:0.006515:0.006644:0.004563:0.003986:0.007644:0.007173:0.003986:0.006644:0.002352:0.011030:0.008020:0.002352:0.008032:0.007173:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.003398:0.003692:0.003540:0.007691:0.011030:0.006644:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
J Glaucoma. :@0.846102:0.875172:0.927088:0.875172:0.927088:0.862897:0.846102:0.862897:0.005668:0.006644:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.003257:0.003257
2019;28(1):75-79:@0.544266:0.886729:0.635023:0.886729:0.635023:0.874454:0.544266:0.874454:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515
18  singh p, Kuldeep K, Tyagi M, :@0.519065:0.898286:0.714598:0.898286:0.714598:0.886011:0.519065:0.886011:0.006515:0.006515:0.003257:0.008914:0.005856:0.002352:0.007173:0.007914:0.007173:0.004939:0.006961:0.003257:0.004939:0.006950:0.007150:0.002352:0.008055:0.007644:0.007644:0.008020:0.004939:0.006950:0.003257:0.004939:0.005009:0.006303:0.008032:0.007914:0.002352:0.004939:0.010807:0.003257:0.003257
et al:@0.716280:0.898286:0.743232:0.898286:0.743232:0.886011:0.716280:0.886011:0.007644:0.003986:0.004939:0.008032:0.002352
. Glaucoma drainage devices. :@0.743232:0.898286:0.927100:0.898286:0.927100:0.886011:0.743232:0.886011:0.003257:0.004939:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.004939:0.008055:0.003540:0.008032:0.002352:0.007173:0.008032:0.007914:0.007644:0.004939:0.008055:0.007644:0.006515:0.002352:0.007608:0.007644:0.004563:0.003257:0.003257
Journal of Clinical Ophthalmology and Research:@0.544266:0.909843:0.829075:0.909843:0.829075:0.897568:0.544266:0.897568:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.004680:0.007702:0.003692:0.004692:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.004704:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.007702:0.007914:0.006303:0.004692:0.008032:0.007173:0.008055:0.004692:0.007138:0.007644:0.004563:0.007644:0.008032:0.003540:0.007608:0.007173
 2013. May-Aug; :@0.829075:0.909843:0.927100:0.909843:0.927100:0.897568:0.829075:0.897568:0.004692:0.006515:0.006515:0.006515:0.006515:0.003257:0.004692:0.010807:0.008032:0.006303:0.003904:0.008702:0.007150:0.007914:0.003257:0.003257
1(1):77-82.:@0.544266:0.921400:0.602450:0.921400:0.602450:0.909125:0.544266:0.909125:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
19  Lim Ks, Allan BDs, Lloyd AW, :@0.519065:0.932957:0.713999:0.932957:0.713999:0.920682:0.519065:0.920682:0.006515:0.006515:0.003257:0.008914:0.005433:0.002352:0.011030:0.005056:0.006950:0.005856:0.003257:0.005056:0.008702:0.002352:0.002352:0.008032:0.007173:0.005056:0.006750:0.008749:0.005856:0.003257:0.005056:0.005433:0.002352:0.007702:0.006303:0.008055:0.005056:0.008702:0.011289:0.003257:0.003257
et al.:@0.715798:0.932957:0.746125:0.932957:0.746125:0.920682:0.715798:0.920682:0.007644:0.003986:0.005056:0.008032:0.002352:0.003257
 Glaucoma drainage devices: :@0.746125:0.932957:0.927088:0.932957:0.927088:0.920682:0.746125:0.920682:0.005056:0.010254:0.002352:0.008032:0.007150:0.007608:0.007702:0.011030:0.008032:0.005056:0.008055:0.003540:0.008032:0.002352:0.007173:0.008032:0.007914:0.007644:0.005056:0.008055:0.007644:0.006515:0.002352:0.007608:0.007644:0.004563:0.003257:0.003257
past, present, and future. :@0.544266:0.944514:0.690656:0.944514:0.690656:0.932239:0.544266:0.932239:0.008020:0.008032:0.004563:0.003986:0.003257:0.003257:0.008020:0.003540:0.007644:0.004563:0.007644:0.007173:0.003986:0.003257:0.003257:0.008032:0.007173:0.008055:0.003257:0.003692:0.007150:0.003986:0.007150:0.003540:0.007644:0.003257:0.003257
Br J Ophthalmol.:@0.690633:0.944514:0.784401:0.944514:0.784401:0.932239:0.690633:0.932239:0.006750:0.003540:0.003257:0.005668:0.003257:0.010219:0.008020:0.007173:0.003986:0.007173:0.008032:0.002352:0.011030:0.007702:0.002352:0.003257
 :@0.709848:0.944514:0.713105:0.944514:0.713105:0.932239:0.709848:0.932239:0.003257
 1998; 82:1083-1089:@0.784401:0.944514:0.892539:0.944514:0.892539:0.932239:0.784401:0.932239:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515